Financial Summary (All financials)
| In millions, except per share items | Jan-31-17 | Jan-31-16 | Jan-31-15 | Jan-31-14 | Jan-31-13 |
| Revenues | 95.5 | 76.0 | 61.1 | 47.2 | 36.3 |
| Revenue growth | 25.6% | 24.3% | 29.4% | 30.0% | |
| Cost of goods sold | 57.8 | 47.1 | 38.4 | 29.5 | 17.3 |
| Gross profit | 37.7 | 28.9 | 22.7 | 17.7 | 19.1 |
| Gross margin | 39.5% | 38.0% | 37.2% | 37.4% | 52.5% |
| Sales and marketing | 40.2 | 34.8 | 28.9 | 20.5 | 15.4 |
| Research and development | 18.2 | 15.7 | 11.9 | 9.1 | 6.6 |
| General and administrative | 15.9 | 14.5 | 10.1 | 7.9 | 5.4 |
| EBITA | -16.2 | -20.4 | -14.8 | -11.9 | -8.3 |
| EBITA margin | -17.0% | -26.9% | -24.2% | -25.2% | -22.9% |
| Amortization of intangibles | | | 0.7 | 0.7 | 0.7 |
| EBIT | -16.2 | -20.4 | -15.5 | -12.6 | -9.1 |
| EBIT margin | -17.0% | -26.9% | -25.3% | -26.7% | -24.9% |
| Pre-tax income | -16.7 | -24.4 | -18.3 | -14.5 | -9.2 |
| Income taxes | 0.2 | 0.3 | 0.3 | 0.0 | 0.1 |
| Net income | -16.9 | -24.7 | -18.5 | -14.5 | -9.4 |
| Net margin | -17.7% | -32.5% | -30.3% | -30.8% | -25.8% |
| |
| Diluted EPS | ($0.55) | ($1.33) | ($6.69) | ($5.73) | ($4.16) |
| Shares outstanding (diluted) | 30.6 | 18.5 | 2.8 | 2.5 | 2.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|